MODERATOR:
Ian Hunt, PhD, Global Head of Scientific Engagement Strategy, Novartis Pharma AG

PANELISTS:
Henry C. Chiou, PhD, Senior Director General Manager, Biosciences, Thermo Fisher Scientific (Retired)

Dominic Esposito, PhD, Director, Protein Sciences, Frederick National Laboratory for Cancer Research

Nicola Burgess-Brown, PhD, Professorial Research Fellow, UCL, London; COO, Protein Sciences, Structural Genomics Consortium

David W. Wood, PhD, Professor, Chemical & Biomolecular Engineering, Ohio State University

Deborah Moore-Lai, PhD, Vice President, Protein Sciences, ProFound Therapeutics

Andrew Nixon, PhD, Senior Vice President, Global Head Biotherapeutics Discovery, Boehringer Ingelheim Pharmaceuticals Inc.

Garegin Papoian, PhD, Cofounder & CSO, DeepOrigin

Stephanie Truhlar, PhD, Vice President, Biotechnology Discovery Research, Eli Lilly and Company

Charlotte M. Deane, PhD, Professor, Structural Bioinformatics, Statistics, University of Oxford; Executive Chair, Engineering and Physical Sciences Research Council (EPSRC)